Bupropion-varenicline interactions and nicotine self-administration behavior in rats. - Wikidata - wikimedia - TriplyDB

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

http://www.wikidata.org/entity/Q35091751

about

Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats.Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline Neuropeptide systems and new treatments for nicotine addiction.Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats.Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.

P2860

Q36319552-3FADD996-B7F2-4A85-9A26-FDC554582FAA Q36494806-5DC6275E-08D5-40FC-BB52-D730CF24C91C Q36568217-544EBE7D-2E65-41AE-A941-5267246F9817 Q36927551-28B18983-13E3-4DB4-90FD-9C37AD786F05 Q39059946-56AFDE6A-213F-4E40-A394-D1743475B391 Q41861355-189F6C4A-F355-46F9-9A41-DCC36DED1F95 Q42130425-B83962A8-757A-43A0-A852-B3BFF613C5DA Q50175904-761B4B09-2EE5-4651-92EB-F4725E14B1B3

P2860

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

http://www.wikidata.org/entity/Q35091751

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@ast

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@en

type

label

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@ast

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@en

prefLabel

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@ast

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@en

P1433

Q35091751-3FF2C9A4-C514-42B3-A651-313AE10907FE

P1476

Q35091751-BB312591-1587-4771-86DB-94B4F2DB0996

P2093

Q35091751-261830A6-FF9C-47D7-9448-443EB3957515

Q35091751-30C0D874-AB55-4093-86AC-E95810070EB2

Q35091751-7A152A02-A4E1-4B16-8C11-1D76E62FAED4

Q35091751-B798D1E8-B99C-4488-B800-C36EEDD777CE

Q35091751-ED10A4C3-55FE-45D0-8C76-928CA6AE522D

P2860

Q35091751-004B2429-89D6-4035-9A17-699DA571FCA2

Q35091751-032AA63E-B715-4C66-A594-A180AFF2DC85

Q35091751-107883BF-50FD-40E9-8944-8E930C674444

Q35091751-1C639B8B-4FBE-4E25-8BA8-437635D1BD0C

Q35091751-23AF8057-F064-4B6C-869B-99AB0438F1BD

Q35091751-31A8EFB3-C414-4E8F-A847-F2D1A72D979B

Q35091751-329E6AA8-13C7-4C0F-A218-5876414C0F2C

Q35091751-3C427F61-DE4B-4CE7-8B93-C70FC9B635F6

Q35091751-414A2280-D99C-498C-9B3A-7C9493D01E23

Q35091751-42AD2338-77EC-43D5-B88E-C3F4BDF2E43E

P304

Q35091751-27244410-C0C0-4474-90FF-0261E35E700D

P31

Q35091751-F0995BCD-437B-490E-B4D3-94BA2C5BB61F

P356

Q35091751-918A2169-DB67-47E5-A2C9-F2330877C104

P407

Q35091751-6D0F30C5-80BD-4583-8AEB-B48EA3CEB67E

P478

Q35091751-D91EBC4D-9664-4AB6-9EFF-A0BE40019D25

P577

Q35091751-1C270904-1F4D-4C45-89B5-F0A3E0FBF588

P698

Q35091751-263777EF-B9FC-4A9B-9BC5-5010B146548C

P921

Q35091751-DA408B6A-1552-45F9-87C6-2FDA07A128A7

P932

Q35091751-B9DAF64D-6E6E-4249-8DED-FCC45C9F6C9D

P356

J.PBB.2015.01.009

P1433

Pharmacology, Biochemistry and Behavior

P1476

Bupropion-varenicline interactions and nicotine self-administration behavior in rats.

@en

P2093

Brandon J Hall

http://www.w3.org/2001/XMLSchema#string

Corinne Wells

http://www.w3.org/2001/XMLSchema#string

Edward D Levin

http://www.w3.org/2001/XMLSchema#string

Jed E Rose

http://www.w3.org/2001/XMLSchema#string

Susan Slade

http://www.w3.org/2001/XMLSchema#string

P2860

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum

Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.

Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Adapting smoking cessation treatment according to initial response to precessation nicotine patch.

Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm

Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PBB.2015.01.009

http://www.w3.org/2001/XMLSchema#string

P407

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25616031

http://www.w3.org/2001/XMLSchema#string

P921

P932

4331343

http://www.w3.org/2001/XMLSchema#string